Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 4/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MYC | P01106 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | LDHB | P07195 | 1/20 | 0.33 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.33 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL511774 | 0.98 | CA1 (0.50) | CA1ALDH1A1TSHRCA2KDM4E | |
| SCHEMBL11708793 | 0.96 | CA1 (0.49) | CA1ALDH1A1TSHRCA2KDM4E | |
| SCHEMBL8731415 | 0.77 | ALDH1A1 (0.53) | CA1ALDH1A1TSHRCA2KDM4E | |
| SCHEMBL5089061 | 0.77 | GAA (0.45) | CA1ALDH1A1TSHRKDM4EGAA | |
| SCHEMBL13826361 | 0.77 | CA1 (0.46) | CA1ALDH1A1TSHRCA2KDM4E | |
| SCHEMBL3868759 | 0.76 | ALDH1A1 (0.50) | CA1ALDH1A1TSHRCA2KDM4E | |
| Potassium Ion SCHEMBL11708784 | 0.75 | ALDH1A1 (0.43) | CA1ALDH1A1TSHRCA2KDM4E | |
| SCHEMBL1487077 | 0.75 | CA12 (0.47) | CA1ALDH1A1TSHRCA2KDM4E | |
| SCHEMBL7758331 | 0.75 | CA1 (0.45) | CA1CA2KDM4EMYCMEN1 | |
| SCHEMBL7672301 | 0.73 | CA1 (0.45) | CA1ALDH1A1TSHRCA2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8722883-B2 | Pyrimidine sulphonamide derivatives as chemokine receptor modulators | ASTRAZENECA AB (SE) | 2014-05-13 | — | — | US | disclosed |
| EP-1809624-B1 | PYRIMIDINE SULPHONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | ASTRAZENECA AB (SE) | 2013-11-20 | — | — | EP | disclosed |
| US-20130203991-A1 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators | ASTRAZENECA R&D ALDERLY PARK (GB) | 2013-08-08 | — | — | US | disclosed |
| US-8410123-B2 | Pyrimidine sulphonamide derivatives as chemokine receptor modulators | ASTRAZENECA AB (SE) | 2013-04-02 | — | — | US | disclosed |
| US-20130012490-A1 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators | ASTRAZENECA AB (SE) | 2013-01-10 | — | — | US | disclosed |
| US-8269002-B2 | Pyrimidine sulphonamide derivatives as chemokine receptor modulators | ASTRAZENECA AB (SE) | 2012-09-18 | — | — | US | disclosed |
| US-20120157431-A1 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators | ASTRAZENECA AB (SE) | 2012-06-21 | — | — | US | disclosed |
| US-20110124619-A1 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators | ASTRAZENECA AB (SE) | 2011-05-26 | — | — | US | disclosed |
| EP-2311827-A1 | Thiopyrimidine derivative, useful as an intermediate for chemokine receptor modulators. | AstraZeneca AB (SE) | 2011-04-20 | — | — | EP | disclosed |
| EP-2301933-A1 | Thiopyrimidine derivative, useful as an intermediate for chemokine receptor modulators | AstraZeneca AB (SE) | 2011-03-30 | — | — | EP | disclosed |
| WO-1998003496-A1 | FURAN NITRONE COMPOUNDS | CENTAUR PHARMACEUTICALS, INC. (US) | 1998-01-29 | — | — | WO | disclosed |
| EP-0819977-A1 | Oxonol compound, silver halide photographic material and process for the synthesis of oxonol compound | FUJI PHOTO FILM CO., LTD. (JP) | 1998-01-21 | — | — | EP | disclosed |
| US-5272050-A | Silver halide photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1993-12-21 | — | — | US | disclosed |
| EP-0331011-B1 | POLYACRYLATE DISPERSIONS PREPARED WITH A WATER-SOLUBLE CONJUGATED UNSATURATED MONOMER IN THE ABSENCE OF A PROTECTIVE COLLOID | HERCULES INCORPORATED (US) | 1993-01-13 | — | — | EP | disclosed |
| US-4997877-A | Acrylic sulfonate-type polymers | HERCULES INCORPORATED (US) | 1991-03-05 | — | — | US | disclosed |
| EP-0331011-A1 | Polyacrylate dispersions prepared with a water-soluble conjugated unsaturated monomer in the absence of a protective colloid | HERCULES INCORPORATED (US) | 1989-09-06 | — | — | EP | disclosed |
| US-4091213-A | 7-Cyclizedamino-3-heterothiomethyl cephalosporin derivatives | BRISTOL-MYERS COMPANY (US) | 1978-05-23 | — | — | US | disclosed |
| US-4064345-A | ANTIBIOTIC | BRISTOL-MYERS COMPANY (US) | 1977-12-20 | — | — | US | disclosed |
| US-4035381-A | AMPICILLIN, AMOXICILLIN, 5-FORMYL-2-FURANSULFONIC ACID | BRISTOL-MYERS COMPANY (US) | 1977-07-12 | — | — | US | disclosed |
| US-4026888-A | ANTIBIOTICS, BACTERICIDES | BRISTOL-MYERS COMPANY (US) | 1977-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157431-A1 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators | CXCR1, CCR5, ACKR3 | CA1 3243/4885ALDH1A1 2139/4885TSHR 1859/4885 |
| US-20110124619-A1 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators | CXCR1, CCR5, ACKR3 | CA1 3243/4885ALDH1A1 2139/4885TSHR 1859/4885 |
| US-20130203991-A1 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators | CXCR1, CCR5, ACKR3 | CA1 3243/4885ALDH1A1 2139/4885TSHR 1859/4885 |
| US-20130012490-A1 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators | CXCR1, CCR5, ACKR3 | CA1 3190/4885ALDH1A1 1919/4885TSHR 1867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.